Clinical Trial Update: A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of a treatment for moderate to severe dry eye; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Snippet

Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2021-08-11